Confounding Factors in Renal Denervation Trials
Year: 2020
Type: review
Source: Hypertension
Institutions: Brigham and Women's Hospital, Harvard University, Jichi Medical University, SUNY Downstate Health Sciences University, National and Kapodistrian University of Athens, Piedmont Atlanta Hospital, Universitätsklinikum des Saarlandes, Athens Medical Center, University of Pennsylvania, Saarland University, State University of New York, Universitätsklinikum Erlangen
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, CSL Behring, Boston Scientific Corporation, Regeneron Pharmaceuticals, Ironwood Pharmaceuticals, Incorporated, Amarin Corporation, Cytokinetics, Medicines Company, ReCor Medical, Omron Healthcare, Belvoir Media Group, Eisai, Novo Nordisk, Servier, Idorsia Pharmaceuticals, National Institutes of Health, St. Jude Medical, Duke Clinical Research Institute, Daiichi Sankyo Europe
OpenAlex ID: W3087999951